Clinical Trial Update: Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dapagliflozin as a vasculoprotective treatment for septic shock with microcirculatory dysfunction; sponsored by University Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Septic Shock | Phase 3 | Status: NOT_YET_RECRUITING